No.

Publication Date

Citing Article

1

2025

P. Saranya, T. Subha aarthi, D. Kalaivani. Phytochemical analysis and pharmacological properties of Solanum melongena (L.) peel extracts: a potential source of natural therapeutic agents, Vegetos. 2025;   https://doi.org/10.1007/s42535-025-01423-7

2

2025

Luisa Schwarzmüller, Janina Müller, Efstathios-Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Dominic Helm, Cindy Körner, Stefan Wiemann. 2025;   https://doi.org/10.1101/2025.04.28.651009

3

2025

Itqan Al Khalily, Sandra Megantara, Diah Aulifa. Targeting Molecular Pathways in Breast Cancer Using Plant-Derived Bioactive Compounds: A Comprehensive Review, Journal of Experimental Pharmacology. 2025; Volume 17: 375.  https://doi.org/10.2147/JEP.S528132

4

2025

Annapurna Gupta, Fouad Choueiry, Jesse Reardon, Nikhil Pramod, Anagh Kulkarni, Eswar Shankar, Steven T. Sizemore, Daniel G. Stover, Jiangjiang Zhu, Bhuvaneswari Ramaswamy, Sarmila Majumder. Invasive lobular carcinoma: integrated multi-omics analysis reveals silencing of Argininosuccinate synthase and upregulation of nucleotide biosynthesis in tamoxifen resistance, Cell Death & Disease. 2025; 16: 514.  https://doi.org/10.1038/s41419-025-07788-6

5

2025

Rukhsana Gul, Hicham Benabdelkamel, Mushtaq Ahmad Dar, Arwa Bazighifan, Afshan Masood, Salini Scaria Joy, Ousman Mahmood Ousman, Assim A. Alfadda. Exploring the Cytotoxic and Redox-Modulatory Effects of Nanoceria in MCF7 Breast Cancer Cells Using Integrated Molecular and Proteomic Analyses, Antioxidants. 2025; 14: 1361.  https://doi.org/10.3390/antiox14111361

6

2023

Satyam Bhasin, Christopher Dusek, James W. Peacock, Artem Cherkasov, Yuzhuo Wang, Martin Gleave, Christopher J. Ong. Dependency of Tamoxifen Sensitive and Resistant ER+ Breast Cancer Cells on Semaphorin 3C (SEMA3C) for Growth, Cells. 2023; 12: 1715.  https://doi.org/10.3390/cells12131715

7

2024

Cigir Biray Avci, Bakiye Goker Bagca, Behrouz Shademan, Leila Sabour Takanlou, Maryam Sabour Takanlou, Alireza Nourazarian. The future of cancer therapy: exploring the potential of patient-derived organoids in drug development, Frontiers in Cell and Developmental Biology. 2024; 12: 1401504.  https://doi.org/10.3389/fcell.2024.1401504

8

2024

Mirosława Püsküllüoğlu, Izabela Michalak. The therapeutic potential of natural metabolites in targeting endocrine-independent HER-2-negative breast cancer, Frontiers in Pharmacology. 2024; 15: 1349242.  https://doi.org/10.3389/fphar.2024.1349242

9

2025

Shailesh Singh, Claudia Weindorfer, Ajeya Nandi, Chermakani Panneer Selvam, Marcelo Mendes Götze, Megha Das, Andres Falaschini, Youley Tjendra, Melinda M. Boone, Helmut Dolznig, Qing Zhang, Robert Clarke, Christoforos Thomas, Rumela Chakrabarti. DLL1-responsive PD-L1 + tumor-associated macrophages promote endocrine resistance in breast cancer , Science Translational Medicine. 2025; 17: eadr6207.  https://doi.org/10.1126/scitranslmed.adr6207

10

2025

Miah Roney, Kelvin Khai Voon Wong, Md. Nazim Uddin, Kamal Rullah, Abdi Wira Septama, Lucia Dwi Antika, Mohd Fadhlizil Fasihi Mohd Aluwi. Design, synthesis, structural characterization, cytotoxicity and computational studies of Usnic acid derivative as potential anti-breast cancer agent against MCF7 and T47D cell lines, Computational Biology and Chemistry. 2025; 115: 108303108303.  https://doi.org/10.1016/j.compbiolchem.2024.108303

11

2023

Deguang Liang, Yan Feng, Fereshteh Zandkarimi, Hua Wang, Zeda Zhang, Jinnie Kim, Yanyan Cai, Wei Gu, Brent R. Stockwell, Xuejun Jiang. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones, Cell. 2023; 186: 2748.  https://doi.org/10.1016/j.cell.2023.05.003

12

2025

Shreyasi Kundu, P.K. Suresh. Triple Negative Breast Cancer Heterogeneity and Tumour Microenvironment-based Model Systems’ Focus on Druggable Targets, Current Molecular Medicine. 2025; 25: 1450.  https://doi.org/10.2174/0115665240387430250508080548

13

2026

Hagar S. El-Hema, Hadeer A. El-Shazly, Mohamed A. Hawata, Nabil M. Yousif, Modather F. Hussein, Mohamed A. Said, Esraa A. Aidy, Haitham E. Shehata, Adel A.-H. Abdel-Rahman. Expanding the chemical and therapeutic landscape of 5H-Indeno[1,2-b]pyridin-5-one derivatives: Novel anticancer activity, EGFR inhibition, and modulation of HIF–VEGF and PI3K/AKT/mTOR pathways supported by computational insights, Bioorganic Chemistry. 2026; 170: 109476109476.  https://doi.org/10.1016/j.bioorg.2026.109476